Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

allogeneic CD34-positive enriched peripheral blood stem cells

A preparation of allogeneic CD34+ selected peripheral blood stem cells (PBSCs) that can potentially be used for immune reconstitution purposes. Upon administration of the allogeneic CD34-positive enriched PBSCs after a hematopoietic cell transplantation (HCT), these cells may provide memory T-cell (Tm) recovery and potentially prevent viral infections. They potentially reduce the occurrence of graft-versus-host disease (GvHD) without increasing the risk of graft failure or poor graft function.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:allogeneic CD34+ PBSCs
allogeneic CD34+-enriched peripheral blood stem cells
donor-derived CD34-positive PBSCs
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search